1. Home
  2. AOSL vs PVLA Comparison

AOSL vs PVLA Comparison

Compare AOSL & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha and Omega Semiconductor Limited

AOSL

Alpha and Omega Semiconductor Limited

HOLD

Current Price

$20.14

Market Cap

940.9M

Sector

Technology

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$103.37

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOSL
PVLA
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
940.9M
1.1B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
AOSL
PVLA
Price
$20.14
$103.37
Analyst Decision
Buy
Strong Buy
Analyst Count
3
16
Target Price
$24.33
$141.50
AVG Volume (30 Days)
316.2K
298.1K
Earning Date
02-04-2026
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$696,776,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.81
N/A
52 Week Low
$15.90
$11.17
52 Week High
$46.65
$114.69

Technical Indicators

Market Signals
Indicator
AOSL
PVLA
Relative Strength Index (RSI) 42.78 56.83
Support Level $19.71 $99.00
Resistance Level $21.06 $114.69
Average True Range (ATR) 0.71 8.59
MACD 0.10 0.18
Stochastic Oscillator 17.42 62.78

Price Performance

Historical Comparison
AOSL
PVLA

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries. It operates in one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: